Search Results - "Chapuy, B."

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity by Gandhi, M.K., Hoang, T., Law, S.C., Brosda, S., O'Rourke, K., Tobin, J.W.D., Vari, F., Murigneux, V., Fink, L., Gunawardana, J., Gould, C., Oey, H., Bednarska, K., Delecluse, S., Trappe, R.U., Merida de Long, L., Sabdia, M.B., Bhagat, G., Hapgood, G., Blyth, E., Clancy, L., Wight, J., Hawkes, E., Rimsza, L.M., Maguire, A., Bojarczuk, K., Chapuy, B., Keane, C.

“…Primary central nervous system lymphoma (PCNSL) is confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic spread. Rarely, PCNSL…”
Get full text

Molecular and clinical diversity in primary central nervous system lymphoma by Hernández-Verdin, I., Kirasic, E., Wienand, K., Mokhtari, K., Eimer, S., Loiseau, H., Rousseau, A., Paillassa, J., Ahle, G., Lerintiu, F., Uro-Coste, E., Oberic, L., Figarella-Branger, D., Chinot, O., Gauchotte, G., Taillandier, L., Marolleau, J.-P., Polivka, M., Adam, C., Ursu, R., Schmitt, A., Barillot, N., Nichelli, L., Lozano-Sánchez, F., Ibañez-Juliá, M.-J., Peyre, M., Mathon, B., Abada, Y., Charlotte, F., Davi, F., Stewart, C., de Reyniès, A., Choquet, S., Soussain, C., Houillier, C., Chapuy, B., Hoang-Xuan, K., Alentorn, A.

“…Primary central nervous system lymphoma (PCNSL) is a rare and distinct entity within diffuse large B-cell lymphoma presenting with variable response rates…”
Get full text

PROTEOMIC PROFILING IDENTIFIES GRANZYME B INHIBITOR SERPIN B9 AS MEDIATOR OF RESISTANCE TO CAR T‐CELL AND BISPECIFIC ANTIBODY TREATMENT IN NODAL B‐CELL LYMPHOMA by Brinkmann, B. J., Roider, T., Capraz, T., Knoll, M., Kolb, C., Liu, Y., Müller‐Tidow, C., Chapuy, B., Sauer, T., Schmitt, M., Rosenwald, A., Huber, W., Dietrich, S.

Get full text

Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration by Chapuy, B, Koch, R, Radunski, U, Corsham, S, Cheong, N, Inagaki, N, Ban, N, Wenzel, D, Reinhardt, D, Zapf, A, Schweyer, S, Kosari, F, Klapper, W, Truemper, L, Wulf, G G

“…Multidrug resistance (MDR) seriously limits the efficacy of chemotherapy in patients with cancer and leukemia. Active transport across membranes is essential…”
Get full text

CYTIDINE DEAMINASES SHAPE THE GENOME OF GERMINAL CENTER B CELL DERIVED LYMPHOMA by Ren, M., Sidiropoulou, E., Tasakis, R. N., Donato, E., Gonzalez‐Menendez, I., Busse, C. E, Luck, T. J, Dolnik, A., Bullinger, L., Trumpp, A., Quintanilla‐Martinez, L., Kreuz, M., Chapuy, B., Hübschmann, D., Siebert, R., Papavasiliou, F N., Sander, S.

Get full text

A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/REFRACTORY (R/R) MYC‐EXPRESSING DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) by Caimi, P.F., Eder, J.P., Jacobsen, E.D., Jacobson, C.A., LaCasce, A.S., Shipp, M.A., Chapuy, B., Labriola‐Tomphins, E., Boisserie, F., Passe, S., Chesné, E., Pierceall, W., Zhi, J., DeMario, M., Vaishampayan, U., Dowlati, A., Shapiro, G.I., Fisher, D.C., Armand, P.

Get full text

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas by RODIG, Scott J, KUTOK, Jeffery L, BEN-NERIAH, Susana, FARINHA, Pedro, SHIPP, Margaret A, PIRIS, Miguel A, GROGAN, Thomas M, PILERI, Stefano A, GASCOYNE, Randy D, MARAFIOTI, Teresa, PATERSON, Jennifer C, NITTA, Hiroaki, WENJUN ZHANG, CHAPUY, Bjoern, TUMWINE, Lynette K, MONTES-MORENO, Santiago, AGOSTINELLI, Claudio, JOHNSON, Nathalie A

“…During B-cell development, precursor B cells transiently express the pre-B-cell receptor composed of μ heavy chain complexed with VpreB and λ5 surrogate light…”
Get full text

Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma by Wulf, G G, Hasenkamp, J, Jung, W, Chapuy, B, Truemper, L, Glass, B

Get full text

Self-tolerance of Human Natural Killer Cells Lacking Self-HLA-specific Inhibitory Receptors by Hasenkamp, J, Borgerding, A, Uhrberg, M, Falk, C, Chapuy, B, Wulf, G, Jung, W, Trümper, L, Glass, B

“…Natural killer (NK) cells identify cells with altered human leucocyte antigen (HLA) expression as targets through lacking engagement of self-HLA-specific…”
Get full text

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma by Fangazio, Marco, Ladewig, Erik, Gomez, Karen, Garcia-Ibanez, Laura, Kumar, Rahul, Teruya-Feldstein, Julie, Rossi, Davide, Filip, Ioan, Pan-Hammarström, Qiang, Inghirami, Giorgio, Boldorini, Renzo, Ott, German, Staiger, Annette M., Chapuy, Björn, Gaidano, Gianluca, Bhagat, Govind, Basso, Katia, Rabadan, Raul, Pasqualucci, Laura, Dalla-Favera, Riccardo

“…Fifty percent of diffuse large B cell lymphoma (DLBCL) cases lack cell-surface expression of the class I major histocompatibility complex (MHC-I), thus…”
Get full text

Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets by Norberg, Erik, Lako, Ana, Chen, Pei-Hsuan, Stanley, Illana A, Zhou, Feng, Ficarro, Scott B, Chapuy, Bjoern, Chen, Linfeng, Rodig, Scott, Shin, Donghyuk, Choi, Dong Wook, Lee, Sangho, Shipp, Margaret A, Marto, Jarrod A, Danial, Nika N

“…Diffuse large B-cell lymphomas (DLBCLs) are a highly heterogeneous group of tumors in which subsets share molecular features revealed by gene expression…”
Get full text

ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug by CHAPUY, Bjoern, PANSE, Melanie, RADUNSKI, Ulf, KOCH, Raphael, WENZEL, Dirk, INAGAKI, Nobuya, HAASE, Detlef, TRUEMPER, Lorenz, WULF, Gerald G

“…Inhibition of BCR-ABL tyrosine kinase activity has evolved as a mainstay of therapy for patients with chronic myeloid leukemia. However, a fraction of leukemic…”
Get full text

LOP27: Association of exosome secretion and drug resistance in aggressive lymphomas model by Aung, T., Vogel, D., Koch, R., Menk, K., Mohring, S.A.I., Chapuy, B., Felmerer, G., Trümper, L., Wulf, G.

Get full text

LOP27: Association of exosome secretion and drug resistance in aggressive lymphomas model by Aung, T., Vogel, D., Koch, R., Menk, K., Mohring, S.A.I., Chapuy, B., Felmerer, G., Trümper, L., Wulf, G.

Get full text

The EHA Research Roadmap: Malignant Lymphoid Diseases by Dreyling, Martin, André, Marc, Gökbuget, Nicola, Tilly, Hervé, Jerkeman, Mats, Gribben, John, Ferreri, Andrés, Morel, Pierre, Stilgenbauer, Stephan, Fox, Christopher, Maria Ribera, José, Zweegman, Sonja, Aurer, Igor, Bödör, Csaba, Burkhardt, Birgit, Buske, Christian, Dollores Caballero, Maria, Campo, Elias, Chapuy, Bjoern, Davies, Andrew, Leval, Laurence, Doorduijn, Jeanette, Federico, Massimo, Gaulard, Philippe, Gay, Francesca, Ghia, Paolo, Grønbæk, Kirsten, Goldschmidt, Hartmut, Kersten, Marie‐Jose, Kiesewetter, Barbara, Landman‐Parker, Judith, Le Gouill, Steven, Lenz, Georg, Leppä, Sirpa, Lopez‐Guillermo, Armando, Macintyre, Elizabeth, Mantega, Maria Victoria Mateos, Moreau, Philippe, Moreno, Carol, Nadel, Bertrand, Okosun, Jessica, Owen, Roger, Pospisilova, Sarka, Pott, Christiane, Robak, Tadeusz, Spina, Michelle, Stamatopoulos, Kostas, Stary, Jan, Tarte, Karin, Tedeschi, Allessandra, Thieblemont, Catherine, Trappe, Ralf Ulrich, Trümper, Lorenz H., Salles, Gilles

“…In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 iming to highlight achievements in the…”
Get full text

Asymptomatic 32 year old female smoker with persistent polyclonal lymphocytosis by Chapuy, B, Wulf, G, Tessen, H W, Griesinger, F, Trümper, L, Schroers, R

“…A 32 year old female smoker (20 pack years) presented with an asymptomatic lymphocytosis of 13,000/nl and splenomegaly. The patient's blood smear showed an…”
Get full text

Identification of a promiscuous HLA DR–restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin by Piesche, Matthias, Hildebrandt, York, Zettl, Florian, Chapuy, Björn, Schmitz, Marc, Wulf, Gerald, Trümper, Lorenz, Schroers, Roland

“…Summary The inhibitor of apoptosis protein survivin is a promising tumor-associated antigen specifically recognized by CD8+ cytotoxic effector T-lymphocytes…”
Get full text

Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives by Wulf, Gerald G, Chapuy, Björn, Trümper, Lorenz

“…Since their initial description by Friedenstein et al. 30 years ago, mesenchymal stem cells have been characterized as a cell population of the bone marrow,…”
Get more information

CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells by Wulf, GG, Boehnke, A, Chapuy, B, Glass, B, Hemmerlein, B, Schroers, R, Brenner, MK, Truemper, L

“…Department of Hematology and Oncology, Georg-August-Universitat Goettingen, Goettingen, Germany. gwulf@med.uni-goettingen.de BACKGROUND AND OBJECTIVES: The…”
Get full text

Targeted-Therapie: Neue Zielstrukturen und Substanzen in der Behandlung maligner Lymphome by Chapuy, B., Borchmann, P., Engert, A., Trümper, L.

Get full text